Literature DB >> 4978385

Effects of clofibrate (Atromid S) on the thyroxine-binding capacity of thyroxine-binding globulin and free thyroxine.

C G McKerron, R L Scott, S P Asper, R I Levy.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4978385     DOI: 10.1210/jcem-29-7-957

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  6 in total

1.  Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement.

Authors:  Jacqueline Jonklaas; Antonio C Bianco; Andrew J Bauer; Kenneth D Burman; Anne R Cappola; Francesco S Celi; David S Cooper; Brian W Kim; Robin P Peeters; M Sara Rosenthal; Anna M Sawka
Journal:  Thyroid       Date:  2014-12       Impact factor: 6.568

Review 2.  A review of studies on the mode of action of clofibrate and betabenzalbutyrate.

Authors:  H J Fallon; L L Adams; R G Lamb
Journal:  Lipids       Date:  1972-02       Impact factor: 1.880

3.  Differential effects of benzodioxane, chroman and dihydrobenzofuran analogs of clofibrate in a Triton hyperlipemic rat model.

Authors:  H A Newman; W P Heilman; D T Witiak
Journal:  Lipids       Date:  1973-07       Impact factor: 1.880

4.  Androgens, oestrogens, and coronary heart disease.

Authors:  R F Heller; H S Jacobs; A Vermeulen; J P Deslypere
Journal:  Br Med J (Clin Res Ed)       Date:  1981-02-07

Review 5.  L-T4 Therapy in the Presence of Pharmacological Interferents.

Authors:  Salvatore Benvenga
Journal:  Front Endocrinol (Lausanne)       Date:  2020-12-22       Impact factor: 5.555

6.  Spurious t3 thyrotoxicosis unmasking multiple myeloma.

Authors:  Marianna Antonopoulou; Arnold Silverberg
Journal:  Case Rep Endocrinol       Date:  2013-07-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.